Eloxx Pharmaceuticals (ELOX) Misses Q2 EPS by 2c

Eloxx Pharmaceuticals (NASDAQ: ELOX) reported Q2 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Eloxx Pharmaceuticals (ELOX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c